Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05080504 · ClinicalTrials.gov registry record
Heart Failure Monitoring With Eko Electronic Stethoscopes (CardioMEMS)
A clinical trial, sponsored by Eko Devices.
- Completed
- Registry status
- 17
- Enrollment target
NCT05080504: Completed study, sponsored by Eko Devices.
NCT05080504 is a clinical trial that has completed, run by Eko Devices. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05080504 has completed, sponsored by Eko Devices.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This study will enroll heart failure (HF) patients who are under active management with an implanted pulmonary artery pressure sensor (CardioMEMS). Subjects will be provided an electronic stethoscope (the Eko DUO) to take at-home heart sound, lung sound, and ECG recordings in conjunction with regimented CardioMEMS measurements. These two datasets will be used to confirm whether an AI/ML model to track HF status can be developed.
Primary Outcome
The primary objective of this proof of concept study is to demonstrate whether Eko data scientists can create an artificial intelligence machine learning (AI/ML) model of pulmonary artery (PA) pressures by analyzing sound and electrical (ECG) signals of heart activity captured by the non-invasive, FDA-cleared, Eko DUO electronic stethoscope.
Interventions
- DEVICE Eko DUO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-05-01 |
What the finished NCT05080504 record still lists
NCT05080504 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Eko DUO is the first listed.
NCT05080504 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05080504 about?
NCT05080504 is a clinical study titled "Heart Failure Monitoring With Eko Electronic Stethoscopes (CardioMEMS)". This study will enroll heart failure (HF) patients who are under active management with an implanted pulmonary artery pressure sensor (CardioMEMS). Subjects will be provided an electronic stethoscope (the Eko DUO) to take at-home heart sound, lung sound, and ECG recordings in conjunction with regime...
What is the current status of trial NCT05080504?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2021-02-01. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT05080504?
The interventions under investigation include: Eko DUO (DEVICE).
Who is sponsoring clinical trial NCT05080504?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI